Frost & Sullivan, Oct 2008, Pages: 95
RESEARCH FOR THE EUROPEAN AUTOIMMUNEDISEASE DIAGNOSTICS MARKET
-Forecasts for the European AutoimmuneDisease Diagnostics Market
--Market Overview
--Research Methodology
--Market Segmentation
GBI Research, Sep 2011, Pages: 95
decade across the five major indications of autoimmune disorders which are Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis and Psoriasis. The average number of patients
GBI Research, Nov 2011, Pages: 88
is expected to boost the myasthenia gravis market in the forecasted period. 1.1 List of Tables
1.2 List of Figures
2 Orphan Autoimmune Disorders to 2017 - Introduction
2.1 Overview
2.2 GBI Research Report
Global Industry Analysts, Inc., Oct 2011, Pages: 749
Techniques & Analytics 3
Product Definition and Scope of Study 3
Rheumatoid Arthritis 4
Multiple Sclerosis 4
Psoriasis 4
Crohns disease 4
2. INDUSTRY OVERVIEW & OUTLOOK 5
AutoimmuneDisease
Decision Resources, Inc., Sep 2011 Autoimmune disorders comprise a myriad of diseases - including various rheumatologic, dermatologic, and gastroenterological (GI) disorders - in which the body’s immune system mistakenly attacks
Frost & Sullivan, Jan 2007
This Frost & Sullivan research service titled European AutoimmuneDisease Therapeutics Market provides an overview of current treatment options, drugs in pipeline and technological advancements
Life Science Analytics, March 2011, Pages: 431
Products vs. Pipeline Products
Company Overview - Pipeline Projects
Legend
--Top 5 Companies in Early Stage AutoimmuneDiseases Products
--Top 5 Companies in Late Stage AutoimmuneDiseases Products
--Top 5
Decision Resources, Inc., Oct 2008, Pages: 29
specialists view therapies in development for the disease?
Scope
- Overview of systemic sclerosis: disease defi nition, pathogenesis, symptoms, diagnosis, disease classifi cation.
- Epidemiology: Diagnosed U
Decision Resources, Inc., Dec 2008, Pages: 26
arthritis? Are there any agents in development for ReA? What role will biologic therapies play in the treatment of ReA?
Scope
- Overview of reactive arthritis: disease definition, pathogenesis, symptoms
Decision Resources, Inc., Dec 2008, Pages: 33
Introduction Sjögren’s syndrome (SS) is one of the most prevalent autoimmunediseases. SS has no cure, and most rheumatologists rely on polypharmacy to sufficiently control patients’ symptoms. New
Elsevier Science and Technology, April 2009, Pages: 266
Antiphospholipid syndrome is an autoimmunedisease which causes abnormal blood clots. It is now recognised as a major cause of common conditions, including stroke, heart attack, miscarriage
GlobalData, Aug 2010, Pages: 27
AutoImmune Inc. is a biopharmaceutical company focused on developing drugs to treat autoimmune and cell mediated inflammatory diseases. The company's products are based on the principles of mucosal
